Equity Analysis

Company Profile

Balance Sheet

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

139.278683

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

82.05

1378.79

EPS(TTM)

Face Value()

Div & Yield %:

28.52

Particulars (Sources Of Funds)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Share Capital	1.47	1.09	1.00	0.01	0.01
Reserves Total	80.59	18.05	5.58	3.13	2.01
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	82.06	19.14	6.58	3.14	2.02
Secured Loans	1.44	2.30	0.19	0.28	0.36
Unsecured Loans	0.00	5.65	0.00	0.00	0.00
Total Debt	1.44	7.95	0.19	0.28	0.36
Other Liabilities	0.46	0.28	0.00	0.00	0.08
Total Liabilities	83.96	27.37	6.77	3.42	2.46
APPLICATION OF FUNDS :
Gross Block	4.15	3.50	0.79	0.72	0.65
Less : Accumulated Depreciation	1.85	0.96	0.48	0.33	0.15
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00
Net Block	2.30	2.54	0.31	0.39	0.50
Lease Adjustment	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.01	0.02	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00
Investments	43.12	20.62	3.07	0.07	0.00
Current Assets, Loans & Advances
Inventories	1.67	0.29	1.59	1.15	0.44
Sundry Debtors	15.20	4.85	2.92	3.60	1.63
Cash and Bank Balance	23.85	3.04	1.15	0.83	1.20
Loans and Advances	10.45	3.17	2.04	1.91	1.50
Total Current Assets	51.16	11.34	7.70	7.50	4.76
Less : Current Liabilities and Provisions
Current Liabilities	12.95	6.40	8.61	7.18	2.69
Provisions	1.14	0.91	0.48	0.41	0.16
Total Current Liabilities & Provisions	14.09	7.31	9.09	7.59	2.85
Net Current Assets	37.07	4.03	-1.40	-0.10	1.91
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.84	0.13	0.04	0.03	0.03
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.84	0.13	0.04	0.03	0.03
Other Assets	0.64	0.01	4.75	3.03	0.01
Total Assets	83.97	27.35	6.77	3.42	2.45
Contingent Liabilities	75.35	94.36	0.00	0.00	0.00